Company intelligence / Profile preview

Ceprodi S.A. Kot

Paris, France

Ownership: Private
Employees: ~20
Development stage: Other

Overview

CEPRODI designs and develops nutritional supplements and meal replacements, particularly for metabolic health and obesity management, with clinical studies mainly conducted through academic collaborations. Their dietary products are enriched in protein and soluble fiber, mainly inulin, and have been investigated in clinical trials for effects on insulin sensitivity, metabolic parameters, and gut microbiota modulation[2][4].

Therapeutic areas: EndocrinologyMetabolic Disorders
Modalities: Dietary SupplementFunctional FoodMeal Replacement
Industry: Food & Nutrition

Partnerships

Pitié-Salpêtrière Hospital (Paris)Academic research groups in France and Belgium

Beyond the preview

Go deeper on Ceprodi S.A. Kot.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ceprodi S.A. Kot.

Explore the full profile